...
首页> 外文期刊>Thoracic cancer. >Nomogram to predict thymoma prognosis: A population‐based study of 1312 cases
【24h】

Nomogram to predict thymoma prognosis: A population‐based study of 1312 cases

机译:NOMAROM预测胸腺瘤预后:1312例的基于人群的研究

获取原文

摘要

A thymoma is a common cancer within the anterior mediastinum; however, the prognostic characteristics have not been established. The aim of this study was to identify the prognostic factors and develop a nomogram for the prognostic prediction of patients with thymoma based on data from the Surveillance, Epidemiology, and End Results (SEER) database. Patients with thymomas diagnosed between 1983 and 2014 were selected. Overall survival (OS) was estimated using the Kaplan-Meier method with the log-rank test. Univariate and multivariate Cox proportional hazards regression analyses were performed to identify the independent prognostic factors, from which a nomogram for thymomas was created. External validation of the nomogram was performed using data from our center. A total of 1312 patients with thymomas were enrolled. Age, tumor size, Masaoka-Koga stage, chemotherapy administered, and surgery type were independent prognostic factors for OS. A nomogram for OS was formulated based on the independent prognostic factors and validated using an internal bootstrap resampling approach, which showed that the nomogram exhibited a sufficient level of discrimination according to the C-index in training (0.713, 95% confidence interval?0.685-0.741) and (0.746, 95% confidence interval 0.625-0.867) validation cohorts. Several prognostic factors for thymomas were identified. The nomogram developed in this study accurately predicted the 5-year and 10-year OS rates of patients with thymomas based on individual characteristics. Risk stratification using the survival nomogram could optimize individual therapy and follow-up. ? 2019 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd.
机译:胸腺瘤是前纵粒内的常见癌症;但是,尚未建立预后特征。本研究的目的是鉴定预后因素,并根据来自监测,流行病学和最终结果(SEER)数据库的数据,制定胸腺瘤患者的预后预测的载体。患有1983年至2014年间诊断的胸腺瘤的患者被选中。使用Log-Sound测试的Kaplan-Meier方法估算总生存(OS)。进行单变量和多元COX比例危害回归分析以鉴定独立的预后因素,从中创建胸腺瘤的NOMOMAR。使用来自我们中心的数据进行NOM图的外部验证。共有1312例胸腺瘤患者。年龄,肿瘤大小,masaoka-Koga阶段,施用化疗,手术类型是OS的独立预后因素。根据独立的预后因素制定了OS的载体,并使用内部自动启动重采采样方法进行验证,这表明载体根据培训中的C型指数表现出足够的歧视水平(0.713,95%置信区间?0.685- 0.741)和(0.746,95%置信区间0.625-0.867)验证队列。确定了胸腺瘤的几种预后因素。本研究开发的墨迹图准确地预测了基于个体特征的胸腺瘤患者的5年和10年的OS率。使用生存载体的风险分层可以优化个体治疗和随访。 ? 2019年的作者。中国肺部肿瘤集团和约翰瓦里和儿子澳大利亚发表的胸癌

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号